Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
55
FDA:55
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device
Phase 1
Completed
- Conditions
- COPD
- Interventions
- Device: Zephir inhaler
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Xiromed LLC
- Target Recruit Count
- 116
- Registration Number
- NCT06254664
- Locations
- 🇺🇸
Vanguard Clinical Research, LLC, Fort Myers, Florida, United States
🇺🇸Clinical Research Solutions - Orlando, Kissimmee, Florida, United States
🇺🇸Clintex Research Group, Miami, Florida, United States
Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Completed
- Conditions
- COPD
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Xiromed LLC
- Target Recruit Count
- 335
- Registration Number
- NCT05986591
- Locations
- 🇺🇸
DownTown LA Research (West Coast), Los Angeles, California, United States
🇺🇸Southwest General Heathcare, Fort Myers, Florida, United States
🇺🇸SIMED Health, Gainesville, Florida, United States
News
No news found